Beijing Daqing Biotechnology

Beijing Daqing Biotechnology is a specialized biopharmaceutical company based in Beijing, China, focusing on the field of regenerative medicine and orthopedic implants. Established in 2003, the company is a pioneer in the development of recombinant human bone morphogenetic protein-2 (rhBMP-2), marketed under the brand name Bongrow. This flagship product is widely used in clinical settings for bone defect repair, non-union fractures, and spinal fusion procedures. Beyond its core rhBMP-2 offering, the company develops various tissue engineering scaffolds and bone graft substitutes. Daqing Biotechnology maintains advanced manufacturing capabilities that adhere to national GMP standards for biologics. The company's mission is to provide innovative solutions for bone and joint health through the integration of biotechnology and clinical medicine.